Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment | Journal of Hematology & Oncology | Full Text
PTC-209 demonstrates on-target effects in MM via downregulation of... | Download Scientific Diagram
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar
BMI-1 downregulation by PTC-209 leads to an increase in H3K27me3... | Download Scientific Diagram
BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse - ScienceDirect
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes | Scientific Reports
PTC209, a Specific Inhibitor of BMI1, Promotes Cell Cycle Arrest and Apoptosis in Cervical Cancer Cell Lines | Anticancer Research
The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells | Blood Cancer Journal
BMI1 in the heart: Novel functions beyond tumorigenesis - eBioMedicine
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
Cancers | Free Full-Text | BMI1-Mediated Pemetrexed Resistance in Non-Small Cell Lung Cancer Cells Is Associated with Increased SP1 Activation and Cancer Stemness | HTML
Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma | Cancer Cell International | Full Text
Targeting of BMI-1 with PTC-209 inhibits glioblastoma development. - Abstract - Europe PMC
Polycomb group protein Bmi1 is required for the neuronal differentiation of mouse induced pluripotent stem cells
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes | Scientific Reports
PTC-209 | BMI-1 Inhibitor | MedChemExpress
Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma | Cancer Cell International | Full Text
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology